Guanajuato Silver completes underground ramp linking San Ignacio and Bolanitos mines
Bitget2026/10/08 18:31Guanajuato Silver completed a 267-meter underground ramp linking San Ignacio with the Bolanitos complex via the Lucero area. Connection targets lower operating costs through faster haulage to the Bolanitos processing plant, improved ventilation, fewer transfer points, larger equipment use. Breakthrough occurred Sept. 30, 2026, ahead of schedule following construction start in May 2026. Ramp development intersected mineralized structures; sampling returned 3.25 meters at 6.02 g/t gold, 145 g/t silver. Drilling started to define potential resource additions from the newly encountered mineralization. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guanajuato Silver Company Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610081430ACCESSWRNAPR_____1234461) on October 08, 2026, and is solely responsible for the information contained therein.
- Guanajuato Silver completed a 267-meter underground ramp linking San Ignacio with the Bolanitos complex via the Lucero area.
- Connection targets lower operating costs through faster haulage to the Bolanitos processing plant, improved ventilation, fewer transfer points, larger equipment use.
- Breakthrough occurred Sept. 30, 2026, ahead of schedule following construction start in May 2026.
- Ramp development intersected mineralized structures; sampling returned 3.25 meters at 6.02 g/t gold, 145 g/t silver.
- Drilling started to define potential resource additions from the newly encountered mineralization.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
London Gold and Silver Vault Data for September 2026
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.